| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/21/2022 | 226.09% | Piper Sandler | $4 → $3 | Maintains | Neutral |
| 09/28/2021 | — | MKM Partners | Upgrades | Sell → Neutral | |
| 12/18/2020 | 878.26% | BMO Capital | → $9 | Downgrades | Market Perform → Underperform |
| 09/23/2020 | 769.57% | Piper Sandler | $10 → $8 | Maintains | Neutral |
| 09/08/2020 | — | Ladenburg Thalmann | Downgrades | Buy → Neutral | |
| 05/15/2020 | 986.96% | Piper Sandler | $12 → $10 | Upgrades | Underweight → Neutral |
| 02/25/2020 | 63.04% | Needham | → $1.5 | Initiates Coverage On | → Hold |
| 01/10/2020 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 01/10/2020 | 8.7% | Piper Sandler | $3 → $1 | Downgrades | Neutral → Underweight |
| 10/22/2019 | 334.78% | Piper Sandler | $7 → $4 | Maintains | Neutral |
| 09/20/2019 | 443.48% | MKM Partners | → $5 | Initiates Coverage On | → Sell |
| 09/16/2019 | 443.48% | Stifel | $7 → $5 | Downgrades | Hold → Sell |
| 07/18/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 07/17/2019 | 878.26% | Ladenburg Thalmann | → $9 | Initiates Coverage On | → Buy |
| 06/06/2019 | — | Stifel | Initiates Coverage On | → Hold | |
| 04/26/2019 | — | Desjardins | Initiates Coverage On | → Buy | |
| 04/17/2019 | 1095.65% | B of A Securities | → $11 | Initiates Coverage On | → Buy |
| 03/05/2019 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 02/25/2019 | — | Jefferies | Initiates Coverage On | → Buy | |
| 02/21/2019 | — | Seaport Global | Initiates Coverage On | → Neutral |
What is the target price for Aurora Cannabis (ACB)?
The latest price target for Aurora Cannabis (NASDAQ: ACB) was reported by Piper Sandler on September 21, 2022. The analyst firm set a price target for $3.00 expecting ACB to rise to within 12 months (a possible 226.09% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aurora Cannabis (ACB)?
The latest analyst rating for Aurora Cannabis (NASDAQ: ACB) was provided by Piper Sandler, and Aurora Cannabis maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Aurora Cannabis (ACB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aurora Cannabis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aurora Cannabis was filed on September 21, 2022 so you should expect the next rating to be made available sometime around September 21, 2023.
Is the Analyst Rating Aurora Cannabis (ACB) correct?
While ratings are subjective and will change, the latest Aurora Cannabis (ACB) rating was a maintained with a price target of $4.00 to $3.00. The current price Aurora Cannabis (ACB) is trading at is $0.92, which is out of the analyst's predicted range.